Isomorphic Labs nears 2 billion funding to supercharge drug design engine

Published on 13 May 2026

Thrive Capital leading a massive push for global expansion

Alphabet’s AI drug discovery venture, Isomorphic Labs, is reportedly close to raising over $2 billion in a round led by Thrive Capital. The fresh capital would strengthen its drug design engine and support rapid global expansion, highlighting how Alphabet is doubling down on high-stakes AI bets beyond search and ads.

Isomorphic Labs is reportedly nearing a $2B+ funding round
Thrive Capital is said to lead the investment
Funds aim to scale its drug design engine and global expansion
The move signals Alphabet’s deeper commitment to AI ventures

#alphabet #funding #biotech #isomorphic labs #ai

Read the full story at The Economic Times

This summarization was done by Beige for a story published on The Economic Times

Isomorphic Labs nears 2 billion funding to supercharge drug design engine

The full experience is on mobile.